Acute Coronary Syndrome Market è segmentato dalla fase di sviluppo clinico (Prodotti di ultima fase (Phase III), Midstage Products (Phase II), Prodotti di prima fase (Pha ....
I principali attori del Global Acute Coronary Syndrome Market includono DalCor Pharmaceuticals, Novartis Pharmaceuticals, Genentech, Sanofi, AstraZeneca, Daiichi Sankyo Company, Johnson & Johnson Service Inc, Amgen, Pfizer, Merck. Co Ltd, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc e CSL Behring.
Acute Coronary Syndrome Market